Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on April 2, 2012, reporting events that occurred on March 30, 2012. The filing details material amendments to the Company's existing debt facilities and financing agreements.
Key Financial Metrics and Debt Structure
The filing does not provide specific revenue, profit, cash flow, or margin figures. The primary financial disclosures relate to debt restructuring and liquidity management:
- Revolving Line of Credit (Domestic): Maturity extended from March 31, 2012, to April 30, 2012. Availability reduced by $3,333,333.
- Revolving Line of Credit (Export-Import Bank): Maturity extended from March 31, 2012, to April 30, 2012.
- Liquidity Covenant: The Bank waived testing of the liquidity ratio financial covenant for the period ended March 31, 2012.
- Commitment Extension: Lenders (Alafi Capital Company LLC and affiliates of Sanderling Venture Partners) extended their obligation to provide $10 million in direct loans or guarantees until April 30, 2012, or until the Company secures $30 million in third-party non-bank financing.
- Equity Issuance: The Company granted 757,346 Extension Warrants to the Lenders with an exercise price of $0.6602 per share.
Material Changes
The material changes reported are strictly related to the modification of debt terms to extend maturity dates and the issuance of warrants to secure continued lender support. No operational or revenue-based changes are disclosed in this filing.
Outlook, Risks, and Contingencies
The Company's ability to maintain liquidity is contingent upon securing $30 million in third-party, non-bank financing by April 30, 2012, or relying on the extended $10 million commitment from existing lenders. The waiver of the liquidity ratio covenant indicates potential pressure on the Company's liquidity metrics as of March 31, 2012. The Lenders are affiliates of Board members Christopher Alafi and Fred A. Middleton.
Investor Verification Checklist
- Verify the Company's progress in securing the $30 million third-party non-bank financing required to satisfy the commitment extension terms.
- Review the full text of the loan modification agreements (Exhibits 10.1 and 10.2) for specific interest rate changes or additional covenants not summarized here.
- Assess the dilution impact of the 757,346 warrants issued at $0.6602 per share.
- Confirm the Company's cash position and burn rate in subsequent filings to evaluate the necessity of further refinancing after April 30, 2012.